<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37506140</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2050-4527</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>7</Issue><PubDate><Year>2023</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Immunity, inflammation and disease</Title><ISOAbbreviation>Immun Inflamm Dis</ISOAbbreviation></Journal><ArticleTitle>Knockdown of KLF5 ameliorates renal fibrosis in MRL/lpr mice via inhibition of MX1 transcription.</ArticleTitle><Pagination><StartPage>e937</StartPage><MedlinePgn>e937</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e937</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1002/iid3.937</ELocationID><Abstract><AbstractText Label="OBJECTIVE">This study aims to elucidate the role of Kruppel-like factor (KLF5) and myxovirus resistance 1 (MX1) in the progression of renal fibrosis in lupus nephritis (LN).</AbstractText><AbstractText Label="METHODS">First, the expression of KLF5 and MX1 was assessed in the peripheral blood of LN patients and healthy participants. Next, the pathological changes in renal tissues were evaluated and compared in BALB/c and MRL/lpr mice, by detecting the expression of fibrosis marker proteins (transforming growth factor-&#x3b2; [TGF-&#x3b2;] and CTGF) and &#x3b1;-SMA, the content of urine protein, and the levels of serum creatinine, blood urea nitrogen, and serum double-stranded DNA antibody. In TGF-&#x3b2;1-induced HK-2 cells, the messenger RNA levels of KLF5 and MX1 were tested by qRT-PCR, and the protein expression of &#x3b1;-SMA, type I collagen (Col I), fibronectin (FN), and matrix metalloproteinase 9 (MMP9) was measured by western blot analysis. Moreover, the relationship between KLF5 and MX1 was predicted and verified.</AbstractText><AbstractText Label="RESULTS">In renal tissues of MRL/lpr mice and the peripheral blood of LN patients, KLF5 and MX1 were highly expressed. Pearson analysis revealed that KLF5 was positively correlated with MX1. Furthermore, KLF5 bound to MX1 promoter and promoted its transcription level. MRL/lpr mice showed substantial renal injury, accompanied by increased expression of &#x3b1;-SMA, TGF-&#x3b2;, CTGF, Col I, FN, and MMP9. Injection of sh-KLF5 or sh-MX1 alone in MRL/lpr mice reduced renal fibrosis in LN, while simultaneous injection of sh-KLF5 and ad-MX1 exacerbated renal injury and fibrosis. Furthermore, we obtained the same results in TGF-&#x3b2;1-induced HK-2 cells.</AbstractText><AbstractText Label="CONCLUSION">Knockdown of KLF5 alleviated renal fibrosis in LN through repressing the transcription of MX1.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tao</LastName><ForeName>Shanshan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangxi Provincial Children's Hospital, The Affiliated Children's Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Xiao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Hematology, Jiangxi Provincial Children's Hospital, The Affiliated Children's Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chai</LastName><ForeName>Wen</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Xiaojie</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangxi Provincial Children's Hospital, The Affiliated Children's Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Weimin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangxi Provincial Children's Hospital, The Affiliated Children's Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Jiangxi Provincial Children's Hospital, The Affiliated Children's Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Meihui</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-9762-1361</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Jiangxi Provincial Children's Hospital, The Affiliated Children's Hospital of Nanchang University, Nanchang, Jiangxi, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Immun Inflamm Dis</MedlineTA><NlmUniqueID>101635460</NlmUniqueID><ISSNLinking>2050-4527</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.24.35</RegistryNumber><NameOfSubstance UI="D020780">Matrix Metalloproteinase 9</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053773">Transforming Growth Factor beta1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C579070">Mx1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C118391">Klf5 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005355" MajorTopicYN="N">Fibrosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020780" MajorTopicYN="Y">Matrix Metalloproteinase 9</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019463" MajorTopicYN="N">Mice, Inbred MRL lpr</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053773" MajorTopicYN="N">Transforming Growth Factor beta1</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">KLF5</Keyword><Keyword MajorTopicYN="N">MRL/lpr mouse</Keyword><Keyword MajorTopicYN="N">lupus nephritis</Keyword><Keyword MajorTopicYN="N">myxovirus resistance 1</Keyword><Keyword MajorTopicYN="N">renal fibrosis</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>19</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>28</Day><Hour>13</Hour><Minute>35</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37506140</ArticleId><ArticleId IdType="pmc">PMC10373570</ArticleId><ArticleId IdType="doi">10.1002/iid3.937</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825&#x2010;835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5477208</ArticleId><ArticleId IdType="pubmed">27821390</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H, Nagafuchi Y, Fujio K. Clinical and immunological biomarkers for systemic lupus erythematosus. Biomolecules. 2021;11(7):928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8301935</ArticleId><ArticleId IdType="pubmed">34206696</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi Y, Zhou X, Cheng F, et al. Increased autophagy is cytoprotective against podocyte injury induced by antibody and interferon&#x2010;&#x3b1; in lupus nephritis. Ann Rheum Dis. 2018;77(12):1799&#x2010;1809.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6800572</ArticleId><ArticleId IdType="pubmed">30209031</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanujam M, Steffgen J, Visvanathan S, Mohan C, Fine JS, Putterman C. Phoenix from the flames: rediscovering the role of the cd40&#x2010;cd40l pathway in systemic lupus erythematosus and lupus nephritis. Autoimmun Rev. 2020;19(11):102668.</Citation><ArticleIdList><ArticleId IdType="pubmed">32942031</ArticleId></ArticleIdList></Reference><Reference><Citation>Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis. 2020;76(2):265&#x2010;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">32220510</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson A, Aranow C, Mackay M. Lupus nephritis: challenges and progress. Curr Opin Rheumatol. 2019;31(6):682&#x2010;688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6812494</ArticleId><ArticleId IdType="pubmed">31389814</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales E, Galindo M, Trujillo H, Praga M. Update on lupus nephritis: looking for a new vision. Nephron. 2021;145(1):1&#x2010;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">33147587</ArticleId></ArticleIdList></Reference><Reference><Citation>Graf L, Dick A, Sendker F, et al. Effects of allelic variations in the human myxovirus resistance protein a on its antiviral activity. J Biol Chem. 2018;293(9):3056&#x2010;3072.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5836113</ArticleId><ArticleId IdType="pubmed">29330299</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir YG, Kocakusak A. The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sj&#xf6;gren's syndrome. Clinics. 2019;74:e631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6558995</ArticleId><ArticleId IdType="pubmed">31241661</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W, Li M, Wang Z, Wang J. IFN&#x2010;&#x3b3; mediates the development of systemic lupus erythematosus. BioMed Res Int. 2020;2020:7176515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7586164</ArticleId><ArticleId IdType="pubmed">33123584</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Mi W, Luo H, et al. Whole&#x2010;genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus. Arthritis Res Ther. 2016;18:162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4942934</ArticleId><ArticleId IdType="pubmed">27412348</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiss H, Salzberger W, Jacobs B, et al. Microrna 155&#x2010;deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane&#x2010;induced lupus. PLoS One. 2017;12(7):e0181015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5515414</ArticleId><ArticleId IdType="pubmed">28719617</ArticleId></ArticleIdList></Reference><Reference><Citation>Rane MJ, Zhao Y, Cai L. Kr&#x3cb;ppel&#x2010;like factors (KLFs) in renal physiology and disease. EBioMedicine. 2019;40:743&#x2010;750.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6414320</ArticleId><ArticleId IdType="pubmed">30662001</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Liu L, Zhou WQ, Cai L, Xu ZG, Rane MJ. Roles of Kr&#xfc;ppel&#x2010;like factor 5 in kidney disease. J Cell Mol Med. 2021;25(5):2342&#x2010;2355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7933973</ArticleId><ArticleId IdType="pubmed">33523554</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Yan Y, Hu Q, Zhang X. RETRACTED: LncRNA MALAT1/microRNA let&#x2010;7f/KLF5 axis regulates podocyte injury in diabetic nephropathy. Life Sci. 2021;266:118794.</Citation><ArticleIdList><ArticleId IdType="pubmed">33232688</ArticleId></ArticleIdList></Reference><Reference><Citation>Li ZL, Lv LL, Wang B, et al. The profibrotic effects of mk&#x2010;8617 on tubulointerstitial fibrosis mediated by the klf5 regulating pathway. FASEB J. 2019;33(11):12630&#x2010;12643.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6902673</ArticleId><ArticleId IdType="pubmed">31451021</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Karypis G, Hippen KL, et al. Genomic view of systemic autoimmunity in mrllpr mice. Genes &amp; Immunity. 2006;7(2):156&#x2010;168.</Citation><ArticleIdList><ArticleId IdType="pubmed">16508641</ArticleId></ArticleIdList></Reference><Reference><Citation>Weening JJ, D'agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65(2):521&#x2010;530.</Citation><ArticleIdList><ArticleId IdType="pubmed">14717922</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Ding W, Wang B, et al. Positive regulation of human pink1 and parkin gene expression by nuclear respiratory factor 1. Mitochondrion. 2020;51:22&#x2010;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">31862413</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Liu Y. Understanding the mechanisms of kidney fibrosis. Nature Reviews Nephrology. 2016;12(2):68&#x2010;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4868356</ArticleId><ArticleId IdType="pubmed">26714578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Wang F, Wang X, Zhang Y, Song L. Elevated creatinine clearance in lupus nephritis patients with normal creatinine. Int J Med Sci. 2021;18(6):1449&#x2010;1455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7893553</ArticleId><ArticleId IdType="pubmed">33628102</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei C, Zhang Y, Zhong X, et al. Ginkgo biloba leaf extract mitigates cisplatin&#x2010;induced chronic renal interstitial fibrosis by inhibiting the epithelial&#x2010;mesenchymal transition of renal tubular epithelial cells mediated by the Smad3/TGF&#x2010;&#x3b2;1 and Smad3/p38 MAPK pathways. Chin Med. 2022;17(1):25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8862328</ArticleId><ArticleId IdType="pubmed">35189929</ArticleId></ArticleIdList></Reference><Reference><Citation>Arazi A, Rao DA, Berthier CC, et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nature Immunol. 2019;20(7):902&#x2010;914.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6726437</ArticleId><ArticleId IdType="pubmed">31209404</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Wang Y, Zhang X, et al. Microrna&#x2010;130b ameliorates murine lupus nephritis through targeting the type I interferon pathway on renal mesangial cells. Arthritis Rheum. 2016;68(9):2232&#x2010;2243.</Citation><ArticleIdList><ArticleId IdType="pubmed">27111096</ArticleId></ArticleIdList></Reference><Reference><Citation>De Masi R, Orlando S, Bagordo F, Grassi T. Ifp35 is a relevant factor in innate immunity, multiple sclerosis, and other chronic inflammatory diseases: A review. Biology. 2021;10(12):1325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8698480</ArticleId><ArticleId IdType="pubmed">34943240</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang LH, Jiang SZ, Guo X, et al. Mir&#x2010;146b&#x2010;5p targets ifi35 to inhibit inflammatory response and apoptosis via jak1/stat1 signalling in lipopolysaccharide&#x2010;induced glomerular cells. Autoimmunity. 2021;54(7):430&#x2010;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">34435525</ArticleId></ArticleIdList></Reference><Reference><Citation>Carnero&#x2010;Montoro E, Barturen G, Povedano E, et al. Epigenome&#x2010;wide comparative study reveals key differences between mixed connective tissue disease and related systemic autoimmune diseases. Front Immunol. 2019;10:1880.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6693476</ArticleId><ArticleId IdType="pubmed">31440254</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez&#x2010;Carrio J, Lopez P, Alperi&#x2010;Lopez M, Caminal&#x2010;Montero L, Ballina&#x2010;Garcia FJ, Suarez A. Irf4 and irgs delineate clinically relevant gene expression signatures in systemic lupus erythematosus and rheumatoid arthritis. Front Immunol. 2018;9:3085.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6330328</ArticleId><ArticleId IdType="pubmed">30666255</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu Y, Yasuda S, Kimura T, et al. Interferon&#x2010;inducible Mx1 protein is highly expressed in renal tissues from treatment&#x2010;na&#xef;ve lupus nephritis, but not in those under immunosuppressive treatment. Modern Rheumatology. 2018;28(4):661&#x2010;669.</Citation><ArticleIdList><ArticleId IdType="pubmed">29189089</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo PW, Huang HT, Ma J, et al. Circular rna&#x2010;0007059 protects cell viability and reduces inflammation in a nephritis cell model by inhibiting microrna&#x2010;1278/shp&#x2010;1/stat3 signaling. Mol Med. 2021;27(1):113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8447523</ArticleId><ArticleId IdType="pubmed">34535085</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlachogiannis NI, Pappa M, Ntouros PA, et al. Association between DNA damage response, fibrosis and type I interferon signature in systemic sclerosis. Front Immunol. 2020;11:582401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7566292</ArticleId><ArticleId IdType="pubmed">33123169</ArticleId></ArticleIdList></Reference><Reference><Citation>Methatham T, Tomida S, Kimura N, Imai Y, Aizawa K. Inhibition of the canonical Wnt signaling pathway by a &#x3b2;&#x2010;catenin/CBP inhibitor prevents heart failure by ameliorating cardiac hypertrophy and fibrosis. Sci Rep. 2021;11(1):14886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8295328</ArticleId><ArticleId IdType="pubmed">34290289</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao L, Yang X, Li Y, et al. Curcumol inhibits klf5&#x2010;dependent angiogenesis by blocking the ros/erk signaling in liver sinusoidal endothelial cells. Life Sci. 2021;264:118696.</Citation><ArticleIdList><ArticleId IdType="pubmed">33157090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutolo MJ, Leir SH, Fossum SL, Browne JA, Harris A. A transcription factor network represses cftr gene expression in airway epithelial cells. Biochem J. 2018;475(7):1323&#x2010;1334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380350</ArticleId><ArticleId IdType="pubmed">29572268</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen WC, Lin HH, Tang MJ. Matrix&#x2010;Stiffness&#x2013;regulated inverse expression of Kr&#xfc;ppel&#x2010;like factor 5 and Kr&#xfc;ppel&#x2010;Like factor 4 in the pathogenesis of renal fibrosis. Am J Pathol. 2015;185(9):2468&#x2010;2481.</Citation><ArticleIdList><ArticleId IdType="pubmed">26212907</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Wang B, Lv L, et al. FIH&#x2010;1&#x2010;modulated HIF&#x2010;1&#x3b1; C&#x2010;TAD promotes acute kidney injury to chronic kidney disease progression via regulating KLF5 signaling. Acta Pharmacol Sin. 2021;42(12):2106&#x2010;2119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8633347</ArticleId><ArticleId IdType="pubmed">33658705</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang HF, Chen L, Luo J, He HX. Klf5 is involved in regulation of ifitm1, 2, and 3 genes during h5n1 virus infection in a549 cells. Cell Mol Biol. 2016;62(13):65&#x2010;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">28040064</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>